​Kembara Xtra - Medicine - Erysipelas

​Kembara Xtra - Medicine - Erysipelas 
Introduction 

Distinct kind of cellulitis: an acute, well-demarcated, superficial bacterial skin infection (most usually on face or leg) with lymphatic involvement, nearly always caused by Streptococcus pyogenes. Most commonly affects the face or legs.
Typically acute, however a chronic recurrent variant can also exist Nonpurulent Skin and exocrine system(s) are the ones that are impacted by this condition 

Epidemiology 

Infants, children, and adults older than 45 years make up the majority of patients.
Most prevalent among those older than 75 years.There is no bias based on gender or race. Incidence
Approximately one in one thousand people will contract erysipelas each year.
Since the 1980s, there has been a growing incidence of.
Prevalence Unknown


Causes and effects: etiology and pathophysiology 
Group A streptococci are known to cause inflammation by activating the contact system, which is a proinflammatory pathway that also has antithrombotic activity. This results in the release of proteinases and cytokines that promote inflammation.
The production of antimicrobial peptides and the release of bradykinin, which is a peptide that causes inflammation, both contribute to an increase in vascular permeability, which in turn causes fever and pain.
Erysipelas is characterized by a series of symptoms including fever, pain, erythema, and edema. These symptoms are caused by a chain reaction that begins when the M proteins found in the cell wall of group A streptococci interact with neutrophils. This interaction leads to the secretion of heparin-binding protein, which is an inflammatory mediator that also induces vascular leakage.
Most typically, beta-hemolytic streptococci of group A; most commonly, Streptococcus pyogenes; occasionally, additional Streptococcus groups C and G
Occasionally, group B streptococci or Staphylococcus aureus may be the cause of the infection.

factors of danger 
A breakdown in the skin's protective barrier, which can be caused by things like surgical incisions, insect bites, eczematous lesions, local trauma, abrasions, dermatophytic infections, and intravenous drug use (IVDU).
Diseases that last for a long time, such as diabetes, malnutrition, nephrotic syndrome, and heart failure ● Immunocompromised (HIV)/debilitated
Leg ulcers and stasis dermatitis Toe-web intertrigo and lymphedema Fissured skin (particularly around the nose and ears) Toe-web intertrigo and lymphedema

Venous/lymphatic insufficiency (saphenectomy, varicose veins of leg, phlebitis, radiation, mastectomy, lymphadenectomy); Alcohol misuse; Morbid obesity; Recent streptococcal pharyngitis; Varicella; Varicella zoster (chicken pox); Varicella zoster (chicken pox); Varicell

The Standard Procedure 
● Good skin hygiene
It is advised that underlying medical problems be effectively handled first, such as stasis dermatitis and tinea pedis.
Shaving the face within five days of developing facial erysipelas increases the risk of a second outbreak of the condition in men.
In cases of recurrence, it is important to investigate additional potential sources of streptococcal infection, such as the tonsils and sinuses.
Patients who suffer from edema in their lower extremities should be strongly encouraged to wear compression stockings.
Patients who have experienced more than two episodes in a period of one year should have suppressive prophylactic antibiotic medication, such as penicillin, taken into consideration.
Group B Concerns Regarding Children's Health Erysipelas in newborns and babies may have streptococcus as the etiological agent.

Providing a Historical Account or a Diagnosis 
Before the skin eruption of erysipelas, patients may experience prodromal symptoms such as moderate to high-grade fever, chills, headache, malaise, anorexia, typically during the first 48 hours, vomiting, and arthralgias.

Caution 

It is essential to differentiate erysipelas from an infection caused by methicillin-resistant Staphylococcus aureus (MRSA), which typically manifests with an indurated core, considerable pain, and later indications of abscess formation. Erysipelas is characterized by a rash that resembles a rash.

The Patient's Clinical Examination 

The patient has a fever that ranges from moderate to high levels, and as a result, they have a tachycardia. Hypotension is a possibility.
Erysipelas can be distinguished from other skin diseases by the fact that the patient suffers from a fever while they have the condition.
There is a possibility that you will experience vomiting and headaches.

Sudden appearance of severe erythema; well defined and excruciatingly painful plaque 
● Peau d'orange appearance

Erythema involving the skin of both the face and the ear, which suggests erysipelas. Milian ear sign
It is possible for vesicles and bullae to form, but their presence is not always guaranteed.
● Desquamation may occur later.
● Lymphangitis
Localization (most often affecting only one side of the body; if both sides are affected, an alternate diagnosis should be considered). - Extremities below the waist 70–80% of all instances
- Involvement of the face is much less prevalent (5–20%), particularly the nose and the ears.
– The chronic version of the disease typically returns to the same location as the prior infection, and it may do so many years after the initial incident.
Patients who are taking systemic steroids may be more difficult to diagnose than other patients due to the fact that the anti-inflammatory activity of the steroids may hide the signs and symptoms of the illness.
The medication makes the systemic toxicity go away very quickly; the skin lesions crust over between days 5 and 10, but they normally heal without leaving scars.
The facial involvement of senior patients typically manifests in the form of a butterfly pattern. In most cases, papules are not present, and instead, there is regional lymphadenopathy along with lymphangitic streaking.

Considerations Relating to Children
Face, scalp, and leg involvement are common in older children due to the excoriations that occur while scratching in atopic dermatitis, which allows for an easy port of entry. Abdominal involvement is more common in babies, particularly around the umbilical stump.

Considerations Regarding the Aged
There is a possibility that fever will not be a noticeable symptom. Eighty percent of cases involve the lower extremities. The remainder are often located on the face.
Patients who are weak and already have some form of heart disease may be at risk for developing high-output cardiac failure.
More prone to the development of problems 

Differential Diagnosis 
Cellulitis (the margins are not as evident and the condition does not affect the ear.) 
Necrotizing fasciitis (a condition characterized by widespread disease and increased discomfort). 
Abscess of the skin (feel for any areas of fluctuation)
Deep vein thrombosis (which must be ruled out if clinical suspicion exists)
Gout in its acute phase (Check the patient's history.) 
Bites from insects (Check the patient's history.)
● Dermatophytes
a condition known as impetigo, which has a blistered or crusted appearance and is superficial.
● Ecthyma (ulcerative impetigo)
● Herpes zoster (dermatomal distribution)
a condition known as erythema annulare centrifugum, often known as elevated pink-red rings or bull's-eye marks.  Contact dermatitis, which is characterized by the absence of fever, itching, and pain.
Urticaria composed of giant cells (temporary, wheal-like appearance, intense itching)
● Angioneurotic edema (no fever)
Scarlet fever (widespread rash with indistinct borders and without edema; rash is more frequent early in skin folds; acquires generalized "sandpaper" feeling as it continues) Chickenpox (widespread rash with indistinct borders and with edema)
Toxic shock syndrome (diffuse erythema with signs of involvement in multiple organs)
lupus facial (characterized by a lower rate of fever and the presence of antinuclear antibodies)
Polychondritis (the condition most often affects the ear.)
Here are several other bacterial illnesses that should be considered: Erysipelothrix rhusiopathiae, often known as erysipeloid, is a parasite that can infect employees in the meat, shellfish, fish, and poultry industries. – Human bite: Eikenella corrodens
- Cat/dog bite: Pasteurella multocida/Capnocytophaga canimorsus - Involvement in activities involving salt water: Vibrio vulnificus
- Prolonged contact with brackish or fresh water: Aeromonas hydrophila

Results From the Laboratory 
Patients who are immunosuppressed, critically unwell, patients who have failed first antibiotic therapy, and patients in any of these categories should only undergo diagnostic tests.
Initial Tests (lab, imaging)
● Leukocytosis ● Blood culture (<5% positive)
Streptococci may be cultivated from exudate or noninvolved locations. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels are elevated.

The Interpretation of Tests
It is not necessary to perform a biopsy; however, the findings on the skin would include the following: Dermal and epidermal edema, extending into the SC tissues Peau d'orange appearance caused by edema in the superficial tissue surrounding the hair follicles Vasodilation and enlarged lymphatics Mixed interstitial infiltrate predominantly composed of neutrophils and mononuclear cells Endothelial cell

Myalgias and fever should be treated symptomatically, and an adequate amount of fluid should be consumed.

ice packs applied topically to the affected area elevation of the afflicted limb treatment of any underlying predisposing conditions with the appropriate medication 

Medication: Antibiotics can treat between 50 and 100 percent of illnesses, although it is unknown which antibiotic regimen is the most effective.
Oral administration of antibiotics may be just as effective as intravenous administration, provided that systemic symptoms such as fever and chills are not present.
It's possible that a treatment of antibiotics lasting only five days can be just as curative as one lasting ten.
First Line

Adults who do not have diabetes: extremities

Primary Penicillin G: 1 to 2 million U IV q6h or cefazolin 1 g IV q8h Alternative (if penicillin allergy) Vancomycin 15 mg/kg IV q12h When afebrile, change to an oral regimen of TMP-SMX or clindamycin – Total 10 days, diabetics 

1 to 2 tablets of trimethoprim-sulfamethoxazole dispersible suspension (TMP-SMX) for early mild cases of the infection Severe illness requires treatment with cephalexin 500 mg PO QID in addition to penicillin VK 500 mg PO BID.
MP or MER or ERTA IV with either linezolid 600 mg IV/PO BID or vancomycin IV or daptomycin 4 mg/kg IV q24h – Facial
Primary Vancomycin: 15 milligrams per kilogram of real body weight given intravenously every eight to twelve hours, with a target trough of 15 to 20
○ Alternative
■ Daptomycin 4 mg/kg IV q24h or linezolid 600 mg IV q12h

● Children – Penicillin G ○ 0 to 7 days, <2,000 g = 50,000 U/kg q12h ○ 8 to 28 days, <2,000 g = 75,000 U/kg q8h ○ 0 to 7 days, >2,000 g = 50,000 U/kg q8h ○ 8 to 28 days, >2,000 g = 50,000 U/kg q6h ○ >28 days = 50,000 U/kg/day
– Cefazolin ○ 0 to 7 days, <2,000 g = 25 mg/kg q12h ○ 8 to 28 days, <2,000 g = 25 mg/kg q12h ○ 0 to 7 days, >2,000 g = 25 mg/kg q12h ○ 8 to 28 days, >2,000 g = 25 mg/kg q8h ○ >28 days = 25 mg/kg q8h ● No reported group A streptococci resistance to beta-lactam antibiotics In cases of chronic infections that keep coming back, preventative medication should be administered after the acute infection has been cured. - Penicillin G benzathine: 1.2 million U intramuscularly once every four weeks; alternatively, penicillin VK 500 mg orally twice daily; or azithromycin 250 mg orally three times daily.

If a staphylococcal infection is suspected in a patient or if the patient is in critical condition, a beta-lactamase-stable antibiotic should be considered.
Community-acquired MRSA should be considered, and depending on the level of sensitivity in the area, it could be treated with TMP-SMX DS 1 tablet taken orally twice daily (PO BID), vancomycin 1 g given intravenously (IV) every 12 hours, or doxycycline 100 mg taken orally twice day (PO BID).

Referral 

Repeated infections, lack of response to treatment

Extra Medical Interventions 
After beginning antibiotic treatment, some patients may observe that their erythema has become more intense. It's possible that this is due to the killing of infections, which causes enzymes to be released and leads to an increase in local inflammation. In this situation, treatment with corticosteroids, in addition to antimicrobials, can mildly reduce the amount of time needed for individuals with erysipelas to heal and the amount of time they need to take antibiotics. Consider decreasing the dosage of prednisolone from 30 mg per day over the course of eight days.

Admission 

● Admission criteria/initial stabilization – Patient who has systemic toxicity – Patient who has high-risk factors (such as being elderly, having lymphedema, having had a splenectomy, or having diabetes) – Patient who has failed outpatient care

Intravenous treatment in the event of systemic toxicity or intolerance to oral administration

Criteria for discharge include the absence of signs of systemic toxicity together with the reduction of erythema and edema.

 During the acute phase of an infection, it is recommended that bed rest with elevated extremities be followed by exercise as tolerated. Patient Monitoring
Patients should receive treatment until they are no longer experiencing any symptoms or cutaneous signs.

Drive home the point that it's critical to take all of your medication as directed.


Prognosis 

Patients should make a full recovery if they are treated appropriately. Patients may have a deepening of erythema following the beginning of antibiotic treatment. 
After 24 to 48 hours, the majority of patients respond favorably to treatment.
The mortality rate is less than one percent in patients who are receiving the appropriate treatment.
The creation of bullae is indicative of a prolonged disease course and frequently points to the presence of a concurrent S. aureus infection, which may necessitate antibiotic therapy for MRSA. Chronic edema and scarring may be the outcome of chronic recurrent instances.
Rarely, obstructive lymphadenitis may develop as a consequence of chronic or repeated instances of lymphadenitis.

Complications Recurrent infection Abscess (suggests staphylococcal infection) Necrotizing fasciitis Lymphedema (most prominent risk factor for recurrence) Lymphedema (most prominent risk factor for recurrence) Necrotizing fasciitis
 
Bacteremia, which can result in sepsis Pneumonia (as a result of sepsis or a toxin-producing organism) Meningitis (as a result of sepsis or a toxin-producing organism) Embolism (as a result of sepsis or a toxin-producing organism)

---